|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
|
|---|---|---|---|---|
| REVENUES | ||||
| COST OF REVENUES | ||||
| GROSS PROFIT | ||||
| OPERATING EXPENSES: | ||||
| Research and development expenses | ||||
| Sales and marketing expenses | ||||
| General and administrative expenses | ||||
| Other Income | ||||
| TOTAL OPERATING EXPENSES | ||||
| OPERATING LOSS | ||||
| Interest expenses | ||||
| Other financial (expense) income, net | ||||
| NET COMPREHENSIVE LOSS FOR THE YEAR | ||||
| Net loss per share attributable to common shareholders – basic (in Dollars per share) | ||||
| Net loss per share attributable to common shareholders diluted (in Dollars per share) | ||||
| Weighted average number of common stocks used in computing net loss per share – basic (in Shares) | ||||
| Weighted average number of common stocks used in computing net loss per share diluted (in Shares) | ||||
Loading...